Search Results - Vitkon, Roy

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study

    Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single... by Vitkon, Roy, Netanely, Dan, Levi, Shai, Ziv-Baran, Tomer, Ben-Yzak, Ronit, Katz, Ben-Zion, Benyamini, Noam, Trestman, Svetlana, Mittelman, Moshe, Cohen, Yael, Avivi, Irit

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    COVID-19 in patients with lymphoproliferative diseases during the Omicron variant surge

    COVID-19 in patients with lymphoproliferative diseases during the Omicron variant surge by Bronstein, Yotam, Gat, Roi, Levi, Shai, Cohen, Yael C., Luttwak, Efrat, Benyamini, Noam, Shragai, Tamir, Vitkon, Roy, Neaman, Miriam, Eilaty, Nili, Levi, Mor, Trestman, Svetlana, Perry, Chava, Herishanu, Yair, Avivi, Irit

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: